These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 28465178)

  • 1. Oral delivery of ursolic acid-loaded nanostructured lipid carrier coated with chitosan oligosaccharides: Development, characterization, in vitro and in vivo assessment for the therapy of leishmaniasis.
    Das S; Ghosh S; De AK; Bera T
    Int J Biol Macromol; 2017 Sep; 102():996-1008. PubMed ID: 28465178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and evaluation of a cedrol-loaded nanostructured lipid carrier system for in vitro and in vivo susceptibilities of wild and drug resistant Leishmania donovani amastigotes.
    Kar N; Chakraborty S; De AK; Ghosh S; Bera T
    Eur J Pharm Sci; 2017 Jun; 104():196-211. PubMed ID: 28400285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transport mechanism of chitosan-N-acetylcysteine, chitosan oligosaccharides or carboxymethyl chitosan decorated coumarin-6 loaded nanostructured lipid carriers across the rabbit ocular.
    Li J; Tan G; Cheng B; Liu D; Pan W
    Eur J Pharm Biopharm; 2017 Nov; 120():89-97. PubMed ID: 28867370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study on the efficiency of chitosan-N-acetylcysteine, chitosan oligosaccharides or carboxymethyl chitosan surface modified nanostructured lipid carrier for ophthalmic delivery of curcumin.
    Li J; Liu D; Tan G; Zhao Z; Yang X; Pan W
    Carbohydr Polym; 2016 Aug; 146():435-44. PubMed ID: 27112894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyaluronic acid-coated nanostructured lipid carriers for loading multiple traditional Chinese medicine components for liver cancer treatment.
    Sun S; Guan Q; Shang E; Xiao H; Yu X; Shi L; Zhao C; Guo Y; Lv S; Li Y
    Pak J Pharm Sci; 2020 Jan; 33(1):109-119. PubMed ID: 32122838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ursolic acid rich Ocimum sanctum L leaf extract loaded nanostructured lipid carriers ameliorate adjuvant induced arthritis in rats by inhibition of COX-1, COX-2, TNF-α and IL-1: Pharmacological and docking studies.
    Ahmad A; Abuzinadah MF; Alkreathy HM; Banaganapalli B; Mujeeb M
    PLoS One; 2018; 13(3):e0193451. PubMed ID: 29558494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and characterization of dutasteride-loaded nanostructured lipid carriers coated with stearic acid-chitosan oligomer for topical delivery.
    Noor NM; Sheikh K; Somavarapu S; Taylor KMG
    Eur J Pharm Biopharm; 2017 Aug; 117():372-384. PubMed ID: 28412472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new medium-throughput screening design approach for the development of hydroxymethylnitrofurazone (NFOH) nanostructured lipid carrier for treating leishmaniasis.
    de Souza A; Yukuyama MN; Barbosa EJ; Monteiro LM; Faloppa ACB; Calixto LA; de Barros Araújo GL; Fotaki N; Löbenberg R; Bou-Chacra NA
    Colloids Surf B Biointerfaces; 2020 Sep; 193():111097. PubMed ID: 32417467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-delivery of buparvaquone and polymyxin B in a nanostructured lipid carrier for leishmaniasis treatment.
    Monteiro LM; Löbenberg R; Fotaki N; de Araújo GLB; Cotrim PC; Bou-Chacra N
    J Glob Antimicrob Resist; 2019 Sep; 18():279-283. PubMed ID: 31202979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ursolic acid-loaded chitosan nanoparticles induce potent anti-angiogenesis in tumor.
    Jin H; Pi J; Yang F; Wu C; Cheng X; Bai H; Huang D; Jiang J; Cai J; Chen ZW
    Appl Microbiol Biotechnol; 2016 Aug; 100(15):6643-6652. PubMed ID: 26883344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and optimization of sulforaphane-loaded nanostructured lipid carriers by the Box-Behnken design for improved oral efficacy against cancer: in vitro, ex vivo and in vivo assessments.
    Soni K; Rizwanullah M; Kohli K
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):15-31. PubMed ID: 29183147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanostructured lipid carrier (NLC) coated with Chitosan Oligosaccharides and its potential use in ocular drug delivery system.
    Luo Q; Zhao J; Zhang X; Pan W
    Int J Pharm; 2011 Jan; 403(1-2):185-91. PubMed ID: 20951778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in vivo evaluation.
    Khan S; Baboota S; Ali J; Narang RS; Narang JK
    Drug Dev Ind Pharm; 2016; 42(2):209-20. PubMed ID: 26016780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and tissue distribution of an orally administered mucoadhesive chitosan-coated amphotericin B-Loaded nanostructured lipid carrier (NLC) in rats.
    Tan JSL; Roberts C; Billa N
    J Biomater Sci Polym Ed; 2020 Feb; 31(2):141-154. PubMed ID: 31612804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifungal and Mucoadhesive Properties of an Orally Administered Chitosan-Coated Amphotericin B Nanostructured Lipid Carrier (NLC).
    Ling JTS; Roberts CJ; Billa N
    AAPS PharmSciTech; 2019 Mar; 20(3):136. PubMed ID: 30838459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical Assessment of Ursolic Acid Loaded into Nanostructured Lipid Carriers in Experimental Visceral Leishmaniasis.
    Jesus JA; Sousa IMO; da Silva TNF; Ferreira AF; Laurenti MD; Antonangelo L; Faria CS; da Costa PC; de Carvalho Ferreira D; Passero LFD
    Pharmaceutics; 2021 Jun; 13(6):. PubMed ID: 34205283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of in vitro and in vivo Efficacy of a Novel Amphotericin B-Loaded Nanostructured Lipid Carrier in the Treatment of
    Rebouças-Silva J; Tadini MC; Devequi-Nunes D; Mansur AL; S Silveira-Mattos P; I de Oliveira C; R Formiga F; Berretta AA; Marquele-Oliveira F; Borges VM
    Int J Nanomedicine; 2020; 15():8659-8672. PubMed ID: 33177824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid based nanocarrier system for the potential oral delivery of decitabine: formulation design, characterization, ex vivo, and in vivo assessment.
    Neupane YR; Srivastava M; Ahmad N; Kumar N; Bhatnagar A; Kohli K
    Int J Pharm; 2014 Dec; 477(1-2):601-12. PubMed ID: 25445972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved anti-obesity effect of herbal active and endogenous lipids co-loaded lipid nanocarriers: Preparation, in vitro and in vivo evaluation.
    Lacatusu I; Badea N; Udeanu D; Coc L; Pop A; Cioates Negut C; Tanase C; Stan R; Meghea A
    Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():12-24. PubMed ID: 30889655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of Lipid Core Material on Physicochemical Characteristics of an Ursolic Acid-Loaded Nanostructured Lipid Carrier: An Attempt To Enhance Anticancer Activity.
    Nahak P; Karmakar G; Chettri P; Roy B; Guha P; Besra SE; Soren A; Bykov AG; Akentiev AV; Noskov BA; Panda AK
    Langmuir; 2016 Sep; 32(38):9816-25. PubMed ID: 27588340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.